###begin article-title 0
###xml 53 57 <span type="species:ncbi:10090">mice</span>
B cells drive lymphocyte activation and expansion in mice with the CD45 wedge mutation and Fas deficiency
###end article-title 0
###begin p 1
###xml 29 53 29 53 <email xmlns:xlink="http://www.w3.org/1999/xlink">aweiss@medicine.ucsf.edu</email>
CORRESPONDENCE Arthur Weiss: aweiss@medicine.ucsf.edu
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 404 408 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 998 1002 <span type="species:ncbi:10090">mice</span>
CD45 and Fas regulate tyrosine phosphorylation and apoptotic signaling pathways, respectively. Mutation of an inhibitory wedge motif in CD45 (E613R) results in hyperresponsive thymocytes and B cells on the C57BL/6 background, but no overt autoimmunity, whereas Fas deletion results in a mild autoimmune disease on the same genetic background. In this study, we show that these two mutations cooperate in mice, causing early lethality, autoantibody production, and substantial lymphoproliferation. In double-mutant mice, this phenotype was dependent on both T and B cells. T cell activation required signaling in response to endogenous or commensal antigens, demonstrated by the introduction of a transgenic T cell receptor. Genetic deletion of B cells also prevented T cell activation. Similarly, T cells were necessary for B cell autoantibody production. However, B cells appeared to be intrinsically activated even in the absence of T cells, suggesting that they may drive the phenotype of these mice. These results reveal a requirement for careful control of B cell signaling and cell death in preventing inappropriate lymphocyte activation and autoimmunity.
###end p 3
###begin p 4
###xml 463 464 463 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 465 466 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 767 768 767 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
In the adaptive immune system, multiple barriers minimize the likelihood that a randomly generated antigen receptor will recognize and initiate a response to self-peptide. These barriers are at work throughout the lifetime of antigen receptor-bearing cells, starting with the elimination of self-reactive cells during their development and followed by mechanisms that induce anergy, suppression, or apoptosis of any self-reactive cells escaping to the periphery (1-3). In some rare, inherited autoimmune syndromes, single-gene defects trigger a failure of one of these processes. However, for most autoimmune diseases, including lupus and arthritis, multiple interacting loci with relatively small individual effects are generally necessary for disease pathogenesis (4). Studying how genetic modifiers cooperate to cause disease is thus critical to our understanding of autoimmunity.
###end p 4
###begin p 5
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 389 390 389 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
CD45 plays an essential role in the immune system, regulating lymphocyte development and activation through Src family kinases (SFKs) (5). CD45 maintains SFKs in a primed, quiescent state by dephosphorylating both inhibitory and activating tyrosines. These unphosphorylated SFKs assume an open conformation that can be rapidly activated by phosphorylation of the activation loop tyrosine (6). In the absence of CD45 activity, the inhibitory tyrosine is phosphorylated by the kinase Csk, and the SFK adopts a closed, inactive conformation.
###end p 5
###begin p 6
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 541 542 529 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 783 784 771 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 786 788 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 990 992 978 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 1100 1102 1088 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 725 729 <span type="species:ncbi:10090">mice</span>
###xml 865 869 <span type="species:ncbi:10090">mice</span>
###xml 1119 1123 <span type="species:ncbi:10090">mice</span>
One means of regulating CD45 is by spontaneous homodimerization, which inhibits its activity, preventing SFK activation and antigen receptor signaling (7, 8). The crystal structure of a related phosphatase, receptor protein tyrosine phosphatase alpha (RPTPalpha), revealed a possible mechanism for inhibition by dimerization. The membrane-proximal phosphatase domain of RPTPalpha crystallizes as a symmetric dimer in which a helix-turn-helix motif of one molecule forms a "wedge" and inserts into the catalytic site of the partner molecule (9). The wedge is highly conserved in CD45. Mutating the acidic amino acid at its tip prevented dimerization-mediated inhibition in vitro and, moreover, led to a lupus-like syndrome in mice when knocked into the endogenous CD45 locus (E613R) (8, 10). In a mixed C57BL/6 (B6) and 129 genetic background, the CD45 wedge mutant mice develop a pronounced lymphoproliferative disease (LPD), autoantibodies, and immune complex-mediated glomerulonephritis (10). However, as with many autoimmune phenotypes, much of the disease resolved on a homogenous B6 background (11). B6 CD45 wedge mice still develop very mild lymphoproliferation and elevated IgM levels, but autoantibodies and glomerulonephritis are absent. B cells remain hyperresponsive to various stimuli, suggesting that the CD45 wedge mutant behaves as a hypermorphic allele, but is insufficient to cause autoimmunity on the B6 background.
###end p 6
###begin p 7
###xml 248 252 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr,</italic>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 700 703 700 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 796 799 796 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 985 987 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 988 990 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 1027 1030 1027 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 1202 1204 1202 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 1206 1208 1206 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 1376 1379 1376 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 1561 1564 1561 1564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 1644 1647 1644 1647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 138 144 <span type="species:ncbi:9606">humans</span>
###xml 656 660 <span type="species:ncbi:10090">mice</span>
###xml 800 804 <span type="species:ncbi:10090">mice</span>
###xml 1096 1100 <span type="species:ncbi:10090">mice</span>
###xml 1156 1160 <span type="species:ncbi:10090">mice</span>
###xml 1338 1342 <span type="species:ncbi:10090">mice</span>
In this study, we ask whether the wedge mutation could act as a genetic modifier with other mutations, predisposing mice, and potentially humans, to autoimmunity. We chose to study the complement C4 knockout and a naturally occurring Fas mutation, lpr, based on their ability to induce a mild, slowly progressing autoimmunity on the B6 background. Complement is a component of the innate immune system involved in opsonization and clearance of pathogens and possibly apoptotic bodies (12, 13). Fas, when bound by Fas ligand (FasL), frequently triggers apoptosis on activated cells, and hence is part of the activation-induced cell death (AICD) pathway. In mice, the phenotypes of the C4 knockout and lpr mutation are highly dependent on strain background. Both mixed B6 x 129 C4 knockout and MRL/lpr mice develop robust autoimmune lupus-like disease, characterized by lymphocyte activation, autoantibodies against nuclear components, immune complex deposition, and glomerulonephritis (13-18). However, backcrossing both C4 and lpr to the B6 background mitigates most of their phenotype. In these mice, low levels of autoantibody are detected only in older mice, without evidence of overt organ damage (18, 19). Here, we find that combination of C4 deficiency and the CD45 wedge mutation does not alter disease compared with single-mutant mice. However, the wedge mutation and lpr act synergistically, markedly accelerating autoantibody production, lymphocyte activation, and lymphoproliferation. Thus, the CD45 wedge mutation acts as a potent modifier with the lpr mutation, but not C4 deficiency. In addressing the mechanisms behind the wedge/lpr phenotype, we further demonstrate that T cells, and specifically signaling through the TCR, and B cells are required for lymphoproliferation, suggesting the presence of a positive feedback loop between these two cell types. Moreover, B cells appear to be intrinsically activated, and therefore their activation may be the primary event driving lymphocyte activation and expansion.
###end p 7
###begin title 8
RESULTS AND DISCUSSION
###end title 8
###begin title 9
###xml 11 14 11 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
CD45 wedge/lpr mice die at an accelerated rate with autoantibody production
###end title 9
###begin p 10
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 204 207 204 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 299 302 299 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 408 419 408 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, A&#8211;C</xref>
###xml 449 452 449 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lpr</italic>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
###xml 644 648 <span type="species:ncbi:10090">mice</span>
We generated wedge/lpr double-mutant mice and followed cohorts consisting of 10 mice, 5 male and 5 female, from WT, single-, and double-mutant backgrounds over the course of 1 yr. Of these cohorts, wedge/lpr double-mutant mice showed accelerated autoantibody production and mortality. 100% of wedge/lpr mice developed antinuclear antibodies (ANAs) by 2 mo of age, dsDNA antibodies by 3 mo, and died by 9 mo (Fig. 1, A-C). As previously reported, B6 Lpr mice did not develop low-titer ANAs until 6 mo of age and dsDNA antibodies until 9 mo of age (unpublished data) (18). In contrast, autoantibodies were not detected in wedge, C4, and wedge/C4 mice throughout the yearlong experiment.
###end p 10
###begin p 11
###xml 11 14 11 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 0 83 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD45 wedge/<italic>lpr</italic> double-mutant mice show early lethality and autoantibody production.</bold>
###xml 136 137 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 581 584 580 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
CD45 wedge/lpr double-mutant mice show early lethality and autoantibody production. (A) Kaplan-Meier survival curve from aging cohorts. n = 10 mice per group, 5 males and 5 females. P < 0.0005. (B) Anti-dsDNA ELISA of serum from aging mice, 6-10 mice per group. Error bars represent SEM. Analysis of variance (ANOVA): *, P < 0.05; **, P < 0.005; ***, P < 0.0005. (C) Staining of Hep2 nuclei with serum diluted 1:40 from 2-mo-old animals. Images are representative of three animals per group. Bars, 50 mum. Lymphocyte accumulation in kidney (D) and lungs (E) of 6-mo-old CD45 wedge/lpr mice. Bars, 200 mum.
###end p 11
###begin p 12
###xml 7 10 7 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 296 299 296 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 406 409 406 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 599 614 599 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, D and E</xref>
###xml 782 785 782 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 924 925 924 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 933 934 933 934 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1029 1032 1029 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
###xml 1033 1037 <span type="species:ncbi:10090">mice</span>
In MRL/lpr mice, autoantibodies and early death are often linked to antibody deposition in the kidneys and glomerulonephritis. Proteinuria is commonly used as a marker for kidney damage in these mice, but surprisingly neither immune complex deposition nor proteinuria were detected in CD45 wedge/lpr mice as late as 9 mo of age (unpublished data). Histological examination of kidneys from 6-9-mo-old wedge/lpr mice did, however, reveal increasing amounts of perivascular lymphocyte accumulations with age. The accumulations were most prominent in kidney and lung and, to a lesser extent, the liver (Fig. 1, D and E). We speculate that progressive accumulation of lymphocytes, combined with compression of the lungs from mediastinal lymphadenopathy, contribute to the death of wedge/lpr mice from asphyxiation (Fig. S1, A-C, available at ). Immunohistochemical analysis revealed the cells to consist almost exclusively of CD3+ and CD4+ T cells (Fig. S1, D-G). In addition to the perivascular infiltrates, kidneys from older wedge/lpr mice appeared pale and contained enlarged, hypercellular glomeruli, which could represent early, subclinical renal ischemia (Fig. S1, H-K).
###end p 12
###begin title 13
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
Wedge and lpr mutations cooperate to induce lymphocyte activation and expansion
###end title 13
###begin p 14
###xml 57 60 57 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 213 216 213 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 306 321 306 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, A and B</xref>
###xml 372 380 372 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 434 437 434 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 718 719 718 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 802 805 802 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 848 851 848 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 1033 1035 1033 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 1037 1039 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 1166 1169 1166 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 1225 1233 1225 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 1349 1352 1349 1352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 1382 1383 1370 1371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1396 1397 1384 1385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1516 1519 1504 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 1535 1543 1523 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 471 475 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
###xml 852 856 <span type="species:ncbi:10090">mice</span>
###xml 1170 1174 <span type="species:ncbi:10090">mice</span>
###xml 1353 1357 <span type="species:ncbi:10090">mice</span>
On gross examination, the most striking feature of wedge/lpr mice was marked lymphadenopathy and splenomegaly, which progressed with age (Fig. S1, A and B). Both splenic weight and lymph node cellularity in wedge/lpr double-mutant mice were increased up to 10-fold compared with single-mutant and WT mice (Fig. 2, A and B). The breakdown of lymphocyte subsets is shown in Fig. 2 C. In general, the composition of lymphocytes in wedge/lpr mice is similar to that of wedge mice, which have a greater fraction of CD3 versus CD19 cells and a slightly skewed CD4 to CD8 ratio. The notable exceptions are the reduced percentage of CD4 and, more dramatically, CD8 cells as they are replaced by the substantial increase in CD3+ CD4/CD8 double-negative (DN) T cells. This is a unique subset of T cells found in lpr mice, but is much more prominent in wedge/lpr mice. The origin of these DN cells is controversial, but they are believed to represent a population of activated T cells that fail to undergo AICD as a result of the Fas mutation (17, 18). Although the percentage of some subsets was reduced, the absolute number of all lymphocyte subsets was much higher in wedge/lpr mice as a result of the overall increased cellularity (Fig. 2 D). Based on BrdU incorporation, lymphocyte expansion was a consequence of increased proliferation in vivo. In wedge/lpr mice, approximately60% of CD4+ T cells, CD8+ T cells, and CD19 B cells, had divided and incorporated BrdU over 10 d, a significantly higher percentage than wedge, lpr, and WT cells (Fig. 2 E).
###end p 14
###begin p 15
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 0 91 0 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Lymphocyte expansion in CD45 wedge/<italic>lpr</italic> mice is accompanied by increased cell proliferation.</bold>
###xml 385 386 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 479 480 477 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 509 510 507 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 515 516 513 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 529 530 527 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 536 537 534 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 542 543 540 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 547 548 545 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 827 830 825 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 1101 1102 1097 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1154 1157 1150 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 470 474 <span type="species:ncbi:10090">mice</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
###xml 848 852 <span type="species:ncbi:10090">mice</span>
###xml 983 987 <span type="species:ncbi:10090">mice</span>
Lymphocyte expansion in CD45 wedge/lpr mice is accompanied by increased cell proliferation. (A) Splenic weight of 2-, 4-, and 6-mo-old mice. Mean of three to six mice per time point +/- SEM. ANOVA: *, P < 0.05; **, P < 0.005; ***, P < 0.0005. (B) Total number of cells pooled from inguinal, axillary, brachial, cervical, and mesenteric lymph nodes of 2-mo-old mice. Unpaired Student's t test: ***, P < 0.0005. (C) Lymphocyte subset analysis of lymph nodes from 2-mo-old mice. CD3+ cells are separated into CD4+, CD8+, and DN (CD3+, B220+, CD4-/CD8- [DN]) cells. (D) Mean absolute number of T cell subsets and B cells in lymph nodes from 2-mo-old mice. Error bars represent SEM with two to four mice per group from three independent experiments. (E) BrdU incorporation is increased in CD4 and CD8 T cells and B cells from wedge/lpr mice. 7-8-wk-old mice were given BrdU in their drinking water for 10 d. Shown is the mean percentage of cells positive for intracellular BrdU from four mice per genotype +/- SEM. Data are representative of three independent experiments. (C, D, and E) Unpaired Student's t test, P < 0.05 compared with WT, *; wedge, **; and lpr, ***.
###end p 15
###begin p 16
###xml 77 80 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 272 280 272 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 356 359 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 460 463 460 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 490 493 490 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 577 580 577 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 584 585 584 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 590 594 590 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 779 782 775 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 1075 1078 1071 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 1106 1114 1102 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 783 787 <span type="species:ncbi:10090">mice</span>
###xml 1079 1083 <span type="species:ncbi:10090">mice</span>
Fitting with the observed lymphoproliferation, both peripheral T and B wedge/lpr cells were activated at a higher frequency. In 2-mo-old mice, up to 90% of CD4 and 75% of CD8 T cells in the spleen had already acquired a memory phenotype, defined by up-regulation of CD44 (Fig. 3 A and Fig. S2 A, available at ). An unusual population of CD4 cells found in lpr mice that have up-regulated CD44, but failed to down-regulate CD62L, was likewise expanded in wedge/lpr double mutants. The wedge/lpr memory phenotype cells showed a strong Th1 polarization. A large fraction of wedge/lpr CD4+ CD44high cells produced IFN-gamma, but not IL-4 or -17, upon direct ex vivo stimulation with PMA and ionomycin (Fig. S2 C and not depicted). In addition to increased memory cell markers, wedge/lpr mice have a higher fraction of cells expressing the immediate activation marker CD69 (Fig. S2 B), which is suggestive of ongoing T cell activation. Analysis of B and myeloid cells indicates that these lineages were also activated, as measured by MHC class II and CD86 up-regulation, in wedge/lpr mice relative to controls (Fig. 3 B).
###end p 16
###begin p 17
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T and B cells from wedge/<italic>lpr</italic> mice show signs of activation.</bold>
###xml 185 186 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 190 191 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 248 252 248 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 259 267 259 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low/high</sup>
###xml 284 287 284 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 294 298 294 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 431 432 431 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 450 451 450 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 690 691 688 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 742 745 740 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
T and B cells from wedge/lpr mice show signs of activation. (A) Representative flow cytometric analysis of CD4 memory phenotype cells from 2-mo-old mice. Shown are the percentage of CD3+ CD4+ T cells from lymph node and spleen that are memory (CD44high, CD62Llow/high) and naive (CD44low, CD62Lhigh) cells. Data are representative of two to four mice from three independent experiments. (B) MHC class II and CD86 expression on CD19+ B cells and CD11c+ DCs are shown as the mean MFI for two to four mice per genotype +/- SEM. Data are shown as relative MFI to correct for different antibody clones and fluorophores and are representative of three independent experiments. Unpaired Student's t test P < 0.05 compared with WT, *; wedge, **; and lpr, ***.
###end p 17
###begin title 18
The wedge mutation does not enhance AICD or proliferation in vitro
###end title 18
###begin p 19
###xml 106 109 106 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 489 492 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 503 506 503 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 752 756 <span type="species:ncbi:10090">mice</span>
We next set out to understand the mechanism driving the T cell activation and expansion in the CD45 wedge/lpr double-mutant mice. Based on our observations that wedge B cells are hyperresponsive to stimulation, we hypothesized that wedge T cells might also have a reduced threshold for activation and thus be more susceptible to Fas-mediated AICD (11). Surprisingly, in vitro AICD assays did not reveal any differences in the apoptosis of wedge versus WT T cells (Fig. S3, available at ). lpr and wedge/lpr T cells were resistant to death in these experiments, indicating that induction of death was Fas dependent (Fig. S3 and not depicted). There was also no difference in CD3 plus CD28-induced in vitro proliferation of CD4 or CD8 T cells from young mice among the four genotypes at multiple doses and time points (unpublished data). These results raised the possibility that the wedge mutation has different effects on responses to strong in vitro stimulation versus in vivo endogenous signals.
###end p 19
###begin title 20
TCR antigen recognition and B cells are required for lymphoproliferation
###end title 20
###begin p 21
###xml 263 266 263 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 273 281 273 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 737 740 737 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 747 755 747 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 798 801 798 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 907 910 907 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 981 984 977 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1039 1047 1035 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 1069 1072 1065 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 1081 1084 1073 1076 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1164 1167 1156 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 1301 1304 1293 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 1313 1316 1301 1304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1501 1509 1489 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 741 745 <span type="species:ncbi:10090">mice</span>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
###xml 911 915 <span type="species:ncbi:10090">mice</span>
###xml 985 989 <span type="species:ncbi:10090">mice</span>
###xml 1085 1089 <span type="species:ncbi:10090">mice</span>
###xml 1317 1321 <span type="species:ncbi:10090">mice</span>
To examine the role of endogenous signaling through the TCR, we restricted the T cell repertoire to a single TCR using the ovalbumin peptide-reactive OT2 TCR transgene. The OT2 TCR transgene completely eliminated the presence of memory phenotype T cells in wedge/lpr mice (Fig. 4 B). In these mice, the small fraction of T cells escaping OT2 TCR restriction showed a slight increase in the percentage of memory cells compared with WT OT2. The degree of activation in these cells likely depends on the specific TCR transgene, the efficiency of restriction, and the strain background (Fig. S4, available at ). Restricting the TCR repertoire also corrected the lymphadenopathy and splenomegaly, as well as the survival defect seen in wedge/lpr mice (Fig. 4 A). None of the mice in a cohort of 6 wedge/lpr OT2 mice had died at 6 mo compared with the 50% mortality seen at this time point in nontransgenic wedge/lpr mice (unpublished data). Genetic elimination of T cells using TCRalpha-/- mice also prevented lymphadenopathy and splenomegaly (Fig. 4 A). Furthermore, wedge/lpr TCRalpha-/- mice failed to produce autoantibodies by 5 mo of age (unpublished data). Wedge/lpr B cells must therefore require T cell help to expand and secrete autoantibodies. Interestingly, B cells and DCs from wedge and wedge/lpr TCRalpha-/- mice still expressed higher levels of MHC class II and CD86, suggesting that B cell and DC activation is a T cell-independent effect that results mainly from the wedge mutation alone (Fig. 4 C).
###end p 21
###begin p 22
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TCR signaling and T cells contribute to lymphocyte activation and expansion.</bold>
###xml 198 201 194 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 233 236 229 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 518 519 514 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 543 544 539 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 548 549 544 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 557 558 549 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 565 566 554 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 570 571 559 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 585 586 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 590 591 579 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 599 600 584 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 607 608 589 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 641 645 623 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 675 678 657 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 685 689 667 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 726 727 708 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 859 860 841 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 878 879 860 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 906 909 884 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1138 1139 1114 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1191 1194 1167 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
###xml 306 311 <span type="species:ncbi:10090">mouse</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 495 510 <span type="species:ncbi:10090">transgenic mice</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
###xml 910 914 <span type="species:ncbi:10090">mice</span>
###xml 944 948 <span type="species:ncbi:10090">mice</span>
TCR signaling and T cells contribute to lymphocyte activation and expansion. (A) Splenic weight as an indicator of lymphoproliferation in normal, OT2 TCR transgenic (OT2), T cell-deficient (TCRalpha-/-), and B cell-deficient mice (Ig-/-) comparing 2-mo-old WT and wedge/lpr. Each point represents a single mouse, five to six mice per genotype. Bars represent the mean of the group. ANOVA, P < 0.0001. (B) Representative flow cytometric analysis of CD4 memory phenotype cells in 2-mo-old OT2 TCR transgenic mice. OT2 Tg+ cells were gated as CD3+ CD4+ Valpha2+ Vbeta5+. Tg- cells are CD3+ CD4+ Valpha2- Vbeta5-. Memory phenotype cells are CD44high, whereas naive cells are CD44low, CD62Lhigh. Numbers represent percentage of CD4+ cells. Data are representative of two to four mice from three independent experiments. (C) MHC class II and CD86 expression on CD19+ B cells and CD11c+ DCs from 2-mo-old TCRalpha-/- mice, shown as the mean MFI for 4 mice per genotype +/- SEM. Data are shown as relative MFI to correct for different antibody clones and fluorophores. Data are representative of three independent experiments. Unpaired Student's t test, P < 0.05 compared with WT, *; wedge, **; and lpr, ***.
###end p 22
###begin p 23
###xml 125 128 125 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 177 180 176 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 193 196 192 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 297 305 296 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 360 363 359 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 366 369 365 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 398 401 397 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 404 407 403 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 439 442 438 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 565 568 564 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 664 672 663 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 764 772 763 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 792 795 791 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 798 801 797 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 866 869 865 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 872 875 871 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 977 980 976 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 802 806 <span type="species:ncbi:10090">mice</span>
###xml 840 844 <span type="species:ncbi:10090">mice</span>
###xml 876 880 <span type="species:ncbi:10090">mice</span>
This finding led us to hypothesize that B cell activation may be responsible for initiating the lymphoproliferation in wedge/lpr mice. We therefore crossed the muMT mutation (Ig-/-) onto wedge/lpr mice to eliminate B cells and found that the extent of T cell activation was significantly reduced (Fig. 5 A). The percentage of memory phenotype T cells in wedge/lpr Ig-/- mice was similar to that of lpr Ig-/- T cells, suggesting that wedge/lpr B cells play a role in the activation of T cells. Removal of B cells also reduced the rate of BrdU incorporation in wedge/lpr T cells by 50%, which is consistent with B cells contributing to the proliferation of T cells (Fig. 5 B). In addition, the absence of B cells markedly abrogated lymphadenopathy and splenomegaly (Fig. 4 A) and rescued wedge/lpr Ig-/- mice from premature death. 6 out of 6 mice in a cohort of wedge/lpr Ig-/- mice were healthy at 6 mo (unpublished data). Thus, in contrast to the intrinsic activation of wedge/lpr B cells, T cells appear to be dependent on B cells for both activation and expansion.
###end p 23
###begin p 24
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T cell activation and expansion is reduced in the absence of B cells.</bold>
###xml 193 196 193 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 225 229 225 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 236 244 236 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low/high</sup>
###xml 266 269 266 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 276 280 276 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 440 441 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 471 474 471 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 476 477 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 742 743 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 794 797 792 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
###xml 545 549 <span type="species:ncbi:10090">Mice</span>
T cell activation and expansion is reduced in the absence of B cells. (A) Representative flow cytometric analysis of CD4 memory phenotype cells in lymph nodes from 2-mo-old B cell-deficient (Ig-/-) mice. Memory cells are CD44high, CD62Llow/high; naive cells are CD44low, CD62Lhigh. Data are representative of two to four mice from three independent experiments. (B) T cell BrdU incorporation in the presence and absence of B cells. Normal (n = 2) and B cell-deficient (Ig-/-; n = 4) mice were administered BrdU in their drinking water for 10 d. Mice were 7-8 wk old. Histograms give the mean percentage of CD4 and CD8 cells positive for intracellular BrdU +/- SEM. Data are representative of three independent experiments. Unpaired Student's t test P < 0.05 compared with WT, *; wedge, **; and lpr, ***.
###end p 24
###begin p 25
###xml 410 411 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 521 522 521 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 928 930 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
Based on our data, we propose the following model for the roles of CD45 and Fas in immune homeostasis and autoimmunity. CD45 regulates lymphocyte signaling through the modulation of SFK activity. SFKs control both the early activation of lymphocytes in response to foreign antigen and the low-level survival signal antigen that receptor cells produce in response to continuous exposure to endogenous antigens (6, 20). Mutation of the CD45 wedge results in a hypermorphic CD45 allele that is more competent for signaling (8, 10). Thus, instead of the low-level signal required for maintaining naive cell survival, enhanced signaling in CD45 wedge mutant cells chronically activates a subset of these cells. Several recent studies have suggested that Fas deletes such chronically activated cells. In these studies, deleted cells were activated in response to either endogenous antigens (21, 22) or persistent foreign antigens (23-25). Fas is likely to be important in deleting wedge mutant T and B cells activated by endogenous antigens as well. However, once Fas is removed, these cells survive and proliferate.
###end p 25
###begin p 26
###xml 76 79 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 196 199 196 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 363 366 363 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 385 388 385 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 627 630 627 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 732 735 732 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
Although both T and B cells show increased activation and turnover in wedge/lpr mice, neither cell type alone is sufficient to cause lymphoproliferation. Neither T cell- or B cell-deficient wedge/lpr mice develop lymphadenopathy or splenomegaly. This phenomenon has also been previously documented for B cell deficiency in mixed background wedge mutant mice, MRL/lpr mice, and aged B6/lpr mice, which fail to develop lymphadenopathy, splenomegaly, and glomerulonephritis (11, 26-28). Together, these data suggest the presence of a positive feedback loop between B and T cells that lead to their mutual expansion (29). In wedge/lpr mice, activated APCs, and more specifically B cells, are responsible for initiating this loop. Wedge/lpr B cells express increased levels of the activation markers MHC class II and CD86, even in the absence of T cells. The elevated levels of these markers appear to be cell intrinsic and might make the B cells more effective at presenting endogenous antigens. We postulate that increased presentation of endogenous antigens then activates autoreactive T cells. These activated T cells further activate B cells, resulting in autoantibody production and proliferation of both cell types.
###end p 26
###begin p 27
###xml 158 161 158 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 901 904 901 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 528 533 <span type="species:ncbi:9606">human</span>
###xml 687 695 <span type="species:ncbi:9606">patients</span>
###xml 905 909 <span type="species:ncbi:10090">mice</span>
We have shown that the CD45 wedge mutation can act as a genetic modifier for the development of autoimmunity, but not in all contexts. When combined with the lpr mutation in Fas, the wedge mutation dramatically accelerates and exacerbates the loss of tolerance, lymphocyte activation, and lymphoproliferation. In contrast, the wedge mutation and C4 deficiency do not cooperate despite the strong predisposition of C4 deficiency to result in a lupuslike syndrome. Interestingly, genetic modifiers may be an important factor in a human disease caused by Fas mutations called autoimmune lymphoproliferative syndrome (ALPS). Even though Fas mutations are autosomal dominant, parents of ALPS patients may carry the same mutation but not display any symptoms (30). Subtle differences in the signaling threshold of lymphocytes from these individuals may account for this variable penetrance. Wedge and wedge/lpr mice may therefore serve as useful tools to begin understanding not only the pathogenesis of ALPS but also the roles of B cells and antigen receptor cell responses to endogenous antigens in other autoimmune conditions.
###end p 27
###begin title 28
MATERIALS AND METHODS
###end title 28
###begin title 29
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 29
###begin p 30
###xml 88 91 88 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 253 256 249 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">Mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
CD45 E613R mice, backcrossed at least nine generations to C57BL/6, were bred to C57BL/6 lpr and C4 knockout mice (The Jackson Laboratory). OT2 mice were a gift from M. Peters (University of California, San Francisco, San Francisco, CA). C57BL/6 TCRalpha-/- and muMT mice were obtained from The Jackson Laboratory. Mice were bled monthly for serum antibody analysis. All animals were housed in a specific pathogen-free barrier facility at UCSF, and experimental protocols in this research involving mice were approved by the UCSF Committee for Animal Research (CAR) according to guidelines set by the University of California San Francisco Institutional Animal Care and Use Committee and National Institutes of Health.
###end p 30
###begin title 31
Autoantibody assays.
###end title 31
###begin p 32
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 520 523 520 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 173 178 <span type="species:ncbi:10090">mouse</span>
For ANA analysis, sera was diluted 1:40 in PBS/1% FBS and applied to Hep2 ANA slides (iNOVA) for 30 min at room temperature. Slides were washed and incubated with FITC anti-mouse IgG, and images were captured using a Marianis system with a Sensicam cooled charge-coupled device camera (Cooke) attached to an Axiovert microscope. Anti-dsDNA antibody titers were determined by ELISA, as previously described (10). Serum was diluted 1:100 in blocking buffer, and then diluted in twofold steps up to seven times. Pooled MRL/lpr serum was used as a positive control.
###end p 32
###begin title 33
Histology.
###end title 33
###begin p 34
###xml 351 352 350 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 353 354 352 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 592 593 591 592 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 594 595 593 594 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Tissue for H&E staining was fixed in 10% formalin (Thermo Fisher Scientific) for at least 24 h, embedded in paraffin, sectioned, and stained. For immunohistochemistry, tissue was immersed in OCT, snap frozen in 1,1,1,2 tetrafluoroethane (Thermo Fisher Scientific), and cut into 5-mum sections. Slides were thawed, fixed in acetone, treated with 0.1% H2O2, and blocked according to the manufacturer's instructions (Vector Laboratories). Slides were incubated with primary antibody, followed by biotinylated secondary antibody and ABC Reagent. Slides were incubated with DAB (0.05% DAB, 0.01% H2O2, and 50 mM Tris, pH 7.4), washed, dehydrated, and mounted. Images were captured using a DM 5000B fluorescent microscope equipped with a DFC 350FX digital camera (both from Leica).
###end p 34
###begin title 35
Flow cytometry and antibodies.
###end title 35
###begin p 36
###xml 261 262 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
Pooled lymph nodes (inguinal, brachial, axillary, cervical, and mesenteric) and spleen were homogenized by grinding between frosted slides and passing through a 30-mum filter. Red blood cells were removed from spleen by ammonium chloride lysis treatment. 2 x 106 cells were stained and analyzed immediately or fixed in 1% paraformaldehyde (Electron Microscopy) for analysis the following day. Data were collected on either a FACSCalibur (BD) or CyAn ADP (Dako). Antibodies were conjugated to FITC/Alexa Fluor 488, PE, PE-Texas red, PerCP-Cy5.5, PE-Cy7, Pacific Blue, Pacific Orange, or APC/Alexa Fluor 647. Antibodies used were as follows: CD3, CD11b, CD11c, CD19, CD45R (B220), CD62L, CD69, TCR Valpha2, and Vbeta5 (BD); CD86 (BioLegend); CD4, CD44, and MHC class II (eBioscience); and CD8 (Invitrogen).
###end p 36
###begin title 37
In vivo BrdU incorporation.
###end title 37
###begin p 38
###xml 468 469 468 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were given water containing 0.8 mg/ml BrdU and 2% glucose for 10 d. Single-cell suspensions from lymph node and spleen were stained for extracellular markers with antibodies conjugated to FITC/Alexa Fluor 488, Pacific Blue, and Pacific Orange. Cells were then fixed in 70% ethanol for 30 min on ice, washed, and resuspended in 1% paraformaldehyde/PBS for 30 min at room temperature. Intracellular DNA was digested using DNase solution (50 Kunitz U/ml, 4.2 mM MgCl2, 0.15 M NaCl). Cells were washed, stained with Alexa Fluor 647-conjugated anti-BrdU (PRD-1; Invitrogen), washed again, and analyzed by flow cytometry.
###end p 38
###begin title 39
Intracellular cytokine staining.
###end title 39
###begin p 40
Lymph node cells were stimulated for 5 h with 20 ng/ml PMA and 1 muM ionomycin in the presence of 10 mug/ml Brefeldin A. They were washed, stained for CD3, CD4, CD8, and CD44, and fixed in 2% paraformaldehyde for 20 min at room temperature. Cells were permeabilized and stained using PE-conjugated anti-IL-4, anti-IFN-gamma, anti-IL-17, and anti-IL-10 (BD) for 60 min at room temperature. Cells were analyzed by flow cytometry.
###end p 40
###begin title 41
AICD assay.
###end title 41
###begin p 42
###xml 366 367 364 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 483 484 481 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
Lymph node CD4 T cells were purified by MACS negative selection (Miltenyi Biotec) and stimulated for 3 d in plates coated with 5 mug/ml anti-CD3 (2C11; Harlan) and with 1 mug/ml soluble anti-CD28. At the end of 3 d, dead cells were removed with Lympholyte (Cedarlane Laboratories) according to the manufacturer's instructions. Live cells were resuspended at 0.5 x 106/ml with 50 U/ml IL-2 and incubated for 24 h. After 24 h, dead cells were again removed with Lympholyte and 0.2 x 106 live cells were added to 96-well plates coated with 0, 0.1, and 1.0 mug/ml anti-CD3. Cells were harvested 6-24 h later, stained with Annexin V and 7-AAD (BD) according to the manufacturer's instructions, and analyzed by flow cytometry.
###end p 42
###begin title 43
Proliferation.
###end title 43
###begin p 44
###xml 219 220 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
Lymph node T cells were purified by MACS negative selection (Miltenyi Biotec) and labeled with 2.5 muM CFSE. 96-well plates were coated with 0, 0.1, 1.0, and 10 mug/ml of anti-CD3 (2C11) overnight at 4degreesC. 0.5 x 106 cells were added to each well with or without 1 mug/ml of soluble anti-CD28. Cells were harvested 48-120 h later, stained for CD4 and CD8, and analyzed by flow cytometry.
###end p 44
###begin title 45
Online supplemental material.
###end title 45
###begin p 46
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 284 287 284 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lpr</italic>
###xml 344 347 344 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
Fig. S1 demonstrates the extensive lymphadenopathy and abnormal kidneys in wedge/lpr mice. Fig. S2 shows the memory cell phenotype of CD8 cells in all four genotypes of mice, as well as CD69 expression and cytokine production in CD4 cells. Fig. S3 examines the AICD of WT, Wedge, and Lpr CD4 cells. Fig. S4 shows the results of analyzing wedge/lpr mice on the BALB background. The online supplemental material is available at .
###end p 46
###begin title 47
Supplementary Material
###end title 47
###begin title 48
[Supplemental Material Index]
###end title 48
###begin p 49
We thank A. Roque for his tireless assistance with animal husbandry, T. Defranco, M. Krummel, and A. Abbas for critically reviewing the manuscript, and the Weiss laboratory for helpful comments and suggestions.
###end p 49
###begin p 50
This work was supported by the National Institutes of Health (NIH) Medical Scientist Training Program and by NIH PO1 AI35297.
###end p 50
###begin p 51
The authors have no conflicting financial interests.
###end p 51

